Clinical Trial Update: A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

View source ↗

Summary

A post-marketing surveillance study evaluating the safety of Cervarix HPV-16/18 vaccine when used per the approved prescribing information in Korea has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Neoplasms

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Rectal | Status: COMPLETED | Results posted: 2023-02-23